跳到主要內容

Perceptive Advisors LLC

SEC CIK
0001224962
最新申報
2026/8/14

2021 年第 3 季持倉

持倉截至 2021/9/30,2021/12/3 申報。只含多頭部位,變化是跟 2021 年第 2 季比股數。

機構總覽
持股檔數
138
較 2021 年第 2 季 −10
總值
$68.6 億
較 2021 年第 2 季 −$8.27 億 (−10.8%)
申報日
2021/12/3
修正SEC
Perceptive Advisors LLC 在 2021 年第 3 季的持倉
證券類別股數市值佔組合 %股數變化動作紀錄
BCLS Acquisition CorpG0904B105COM CL A1,000,000$996.0 萬0.1%00.0%不變–
FUSNFusion Pharmaceuticals Inc.COM1,254,607$993.6 萬0.1%−520,560−29.3%減碼歷史
RACBResearch Alliance Corp. IICOM CL A1,000,000$985.0 萬0.1%00.0%不變歷史
PNTPOINT Biopharma Global Inc.COM1,242,879$955.7 萬0.1%+1,242,879新進歷史
ChemoCentryx, Inc.16383L106COM550,000$940.5 萬0.1%+550,000新進–
PMVPPMV Pharmaceuticals, Inc.COM301,714$899.1 萬0.1%−444,843−59.6%減碼歷史
SGHTSight Sciences, Inc.COM390,000$885.3 萬0.1%+390,000新進歷史
FULCFulcrum Therapeutics, Inc.COM294,118$829.7 萬0.1%00.0%不變歷史
PRTAProthena Corp Public Ltd CoSHS100,000$712.3 萬0.1%00.0%不變歷史
CNCEConcert Pharmaceuticals, Inc.COM2,150,641$703.3 萬0.1%00.0%不變歷史
RPIDRapid Micro Biosystems, Inc.CLASS A COM350,000$646.5 萬0.1%+350,000新進歷史
NEPTFNeptune Wellness Solutions Inc.COM10,055,521$608.0 萬0.1%−2,794,185−21.7%減碼歷史
PRVBProvention Bio, Inc.COM948,481$607.0 萬0.1%00.0%不變歷史
TSHATaysha Gene Therapies, Inc.COM SHS320,440$596.7 萬0.1%00.0%不變歷史
Achilles Therapeutics PLC00449L102SPONSORED ADS755,375$588.4 萬0.1%00.0%不變–
PSTXPoseida Therapeutics, Inc.COM787,745$574.3 萬0.1%00.0%不變歷史
ATECAlphatec Holdings, Inc.COM NEW430,900$525.2 萬0.1%−1,369,280−76.1%減碼歷史
DALSDA32 Life Science Tech Acquisition Corp.CLASS A COM500,000$491.5 萬0.1%+500,000新進歷史
TBIOTelesis Bio Inc.COM425,000$473.0 萬0.1%00.0%不變歷史
DRIODarioHealth Corp.COM NEW327,869$447.5 萬0.1%00.0%不變歷史
OBIOOrchestra BioMed Holdings, Inc.ORD SHS450,000$445.1 萬0.1%00.0%不變歷史
RGNXREGENXBIO Inc.COM89,283$374.3 萬0.1%00.0%不變歷史
SRZNSurrozen, Inc.COM500,000$354.0 萬0.1%+500,000新進歷史
YARWYarrow Bioscience, Inc.COM2,330,471$323.9 萬<0.1%−3,443,483−59.6%減碼歷史
SNCEScience 37 Holdings, Inc.COM300,000$294.0 萬<0.1%00.0%不變歷史
TARAProtara Therapeutics, Inc.COM STK421,641$291.8 萬<0.1%00.0%不變歷史
AXSMAxsome Therapeutics, Inc.COM80,420$265.1 萬<0.1%−473,488−85.5%減碼歷史
IMGOImago BioSciences, Inc.COM125,000$250.4 萬<0.1%+125,000新進歷史
KRROKorro Bio, Inc.COM222,222$156.9 萬<0.1%00.0%不變歷史
RACEFerrari N.V.COM6,200$129.7 萬<0.1%00.0%不變歷史
MOTSMotus GI Holdings, Inc.COM1,800,542$124.2 萬<0.1%00.0%不變歷史
Rockley Photonics Holdings LG7614L117*W EXP 08/11/202500,000$119.5 萬<0.1%+500,000新進–
EIGREiger BioPharmaceuticals, Inc.COM139,890$93.4 萬<0.1%00.0%不變歷史
Butterfly Network, Inc.124155110*W EXP 05/27/202233,333$64.2 萬<0.1%00.0%不變–
PHVSPharvaris N.V.COM27,000$47.9 萬<0.1%00.0%不變歷史
SLGCWSomaLogic, Inc.*W EXP 03/01/202110,000$38.0 萬<0.1%+110,000新進歷史
Surrozen, Inc.86889P117*W EXP 08/01/203166,666$19.0 萬<0.1%+166,666新進–
CareMax, Inc.14171W111*W EXP 06/08/20260,000$17.0 萬<0.1%00.0%不變–

選擇權(2 檔)

同一份申報裡的賣權(put)與買權(call)。金額是標的股票的市值,也就是 13F 申報的數字。

Perceptive Advisors LLC 在 2021 年第 3 季的選擇權部位
證券類別賣權買權
ChemoCentryx, Inc.16383L106COM–$1,579 萬
FLNAFilana Therapeutics, Inc.COM$620.8 萬–

2021 年第 2 季之後清倉(34 檔)

2021 年第 2 季季末還持有、這份申報已經沒有的部位。

Perceptive Advisors LLC 在 2021 年第 2 季之後清倉的部位
證券類別2021 年第 2 季股數2021 年第 2 季市值2021 年第 2 季佔組合 %紀錄
KDMNKadmon Holdings, Inc.COM15,711,334$6,080 萬0.8%歷史
MDTMedtronic plcStock450,000$5,586 萬0.7%歷史
DRNADicerna Pharmaceuticals IncCOM800,000$2,986 萬0.4%歷史
EXASExact Sciences CorpCOM233,523$2,903 萬0.4%歷史
NARIInari Medical, Inc.Stock310,437$2,896 萬0.4%歷史
XLRNAcceleron Pharma IncCOM226,760$2,846 萬0.4%歷史
RGENRepligen CorpCOM132,500$2,645 萬0.3%歷史
ARWRArrowhead Pharmaceuticals, Inc.COM315,141$2,610 萬0.3%歷史
COLLCollegium Pharmaceutical, IncCOM978,277$2,313 萬0.3%歷史
FBRXForte Biosciences, Inc.COM685,000$2,303 萬0.3%歷史
STOKStoke Therapeutics, Inc.COM671,978$2,262 萬0.3%歷史
CM Life Sciences II Inc125842203UNIT 02/25/20281,250,000$1,681 萬0.2%–
Catabasis Pharmaceuticals IN14875P206COM NEW7,687,185$1,622 萬0.2%–
Therapeutics Acquisition Cor88339T103COM CL A1,500,000$1,541 萬0.2%–
CVRXCVRx, Inc.COM440,000$1,232 萬0.2%歷史
CTMXCytomX Therapeutics, Inc.COM1,640,957$1,039 萬0.1%歷史
SILKSilk Road Medical IncCOM147,133$704.2 萬0.1%歷史
PRVAPrivia Health Group, Inc.COM135,000$599.0 萬0.1%歷史
AKYAAkoya Biosciences, Inc.COM300,000$580.2 萬0.1%歷史
BCTG Acquisition Corp05492W103COM500,000$569.0 萬0.1%–
MREOMereo BioPharma Group plcSPON ADS1,696,068$537.7 萬0.1%歷史
Consonance HFW Acquisition CG2445M129UNIT 99/99/9999500,000$520.0 萬0.1%–
Longview Acquisition Corp. II54319Q204UNIT 99/99/9999500,000$504.0 萬0.1%–
MRUSMerus N.V.COM175,000$368.7 萬<0.1%歷史
AMWLAmerican Well CorpCL A290,000$364.8 萬<0.1%歷史
CM Life Sciences Inc18978W109COM CL A227,000$318.0 萬<0.1%–
GRTXGalera Therapeutics, Inc.COM254,664$250.3 萬<0.1%歷史
Cerevel Therapeutics HLDNG I15678U102*W EXP 06/09/202133,066$191.4 萬<0.1%–
SGTXSigilon Therapeutics, Inc.COM125,000$134.1 萬<0.1%歷史
SRRASierra Oncology, Inc.COM NEW66,655$129.8 萬<0.1%歷史
SC Health CorpG78516401*W EXP 99/99/999500,000$105.5 萬<0.1%–
PLXPPLx Pharma Winddown Corp.COM57,459$79.3 萬<0.1%歷史
TKNOAlpha Teknova, Inc.COM30,000$71.2 萬<0.1%歷史
TCRRTCR2 Therapeutics Inc.COM30,753$50.5 萬<0.1%歷史